The goal of this work was to develop a simple, robust, and cost-effective assay to identify NOTCH1 PEST domain mutations and also to evaluate the frequency of NOTCH1 mutations in a cohort of CLL patients. This evidence concerns the gene NOTCH1 and B-cell chronic lymphocytic leukemia.